Cargando…

Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis

BACKGROUND: The MRE11/RAD50/NBS1 (MRN) complex plays an essential role in detecting and repairing double-stranded breaks, and thus the potential roles of MRE11, RAD50 and NBS1 proteins in the pathogenesis of various cancers is the subject of investigation. This study was aimed at assessing the three...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Vincent, Chung, Liping, Singh, Amandeep, Lea, Vivienne, Abubakar, Askar, Lim, Stephanie H., Ng, Weng, Lee, Mark, de Souza, Paul, Shin, Joo-Shik, Lee, Cheok Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122630/
https://www.ncbi.nlm.nih.gov/pubmed/30176843
http://dx.doi.org/10.1186/s12885-018-4776-9
_version_ 1783352690287312896
author Ho, Vincent
Chung, Liping
Singh, Amandeep
Lea, Vivienne
Abubakar, Askar
Lim, Stephanie H.
Ng, Weng
Lee, Mark
de Souza, Paul
Shin, Joo-Shik
Lee, Cheok Soon
author_facet Ho, Vincent
Chung, Liping
Singh, Amandeep
Lea, Vivienne
Abubakar, Askar
Lim, Stephanie H.
Ng, Weng
Lee, Mark
de Souza, Paul
Shin, Joo-Shik
Lee, Cheok Soon
author_sort Ho, Vincent
collection PubMed
description BACKGROUND: The MRE11/RAD50/NBS1 (MRN) complex plays an essential role in detecting and repairing double-stranded breaks, and thus the potential roles of MRE11, RAD50 and NBS1 proteins in the pathogenesis of various cancers is the subject of investigation. This study was aimed at assessing the three-protein panel of MRN complex subunits as a potential radiosensitivity marker and evaluating the prognostic and clinicopathological implications of MRN expression in rectal cancer. METHODS: Samples from 265 rectal cancer patients treated with surgery and adjuvant chemoradiotherapy, including samples from 55 patients who were treated with neoadjuvant radiotherapy between 2000 and 2011, were analyzed. Expression of MRN complex proteins in tissue samples was determined by immunohistochemistry. Univariate and multivariate analyses were carried out to identify clinicopathological characteristics that are associated with the MRN three-protein panel expression in rectal cancer samples. RESULTS: In Kaplan–Meier survival analyses, we found that high level expression of MRN complex proteins in postoperative samples was associated with poor disease-free (p = 0.021) and overall (P = 0.002) survival. Interestingly, high MRN expression also correlated with poor disease-free (P = 0.047) and overall (P = 0.024) survival in the neoadjuvant radiotherapy subgroup. In multivariate analysis, combined MRN expression (hazard ratio = 2.114, 95% confidence interval 1.096–4.078, P = 0.026) and perineural invasion (hazard ratio = 2.160, 95% confidence interval 1.209–3.859, P = 0.009) were significantly associated with a worse disease-free survival. CONCLUSIONS: Expression levels of MRN complex proteins significantly predict disease-free survival in rectal cancer patients, including those treated with neoadjuvant radiotherapy, and may have value in the management of these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4776-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6122630
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61226302018-09-05 Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis Ho, Vincent Chung, Liping Singh, Amandeep Lea, Vivienne Abubakar, Askar Lim, Stephanie H. Ng, Weng Lee, Mark de Souza, Paul Shin, Joo-Shik Lee, Cheok Soon BMC Cancer Research Article BACKGROUND: The MRE11/RAD50/NBS1 (MRN) complex plays an essential role in detecting and repairing double-stranded breaks, and thus the potential roles of MRE11, RAD50 and NBS1 proteins in the pathogenesis of various cancers is the subject of investigation. This study was aimed at assessing the three-protein panel of MRN complex subunits as a potential radiosensitivity marker and evaluating the prognostic and clinicopathological implications of MRN expression in rectal cancer. METHODS: Samples from 265 rectal cancer patients treated with surgery and adjuvant chemoradiotherapy, including samples from 55 patients who were treated with neoadjuvant radiotherapy between 2000 and 2011, were analyzed. Expression of MRN complex proteins in tissue samples was determined by immunohistochemistry. Univariate and multivariate analyses were carried out to identify clinicopathological characteristics that are associated with the MRN three-protein panel expression in rectal cancer samples. RESULTS: In Kaplan–Meier survival analyses, we found that high level expression of MRN complex proteins in postoperative samples was associated with poor disease-free (p = 0.021) and overall (P = 0.002) survival. Interestingly, high MRN expression also correlated with poor disease-free (P = 0.047) and overall (P = 0.024) survival in the neoadjuvant radiotherapy subgroup. In multivariate analysis, combined MRN expression (hazard ratio = 2.114, 95% confidence interval 1.096–4.078, P = 0.026) and perineural invasion (hazard ratio = 2.160, 95% confidence interval 1.209–3.859, P = 0.009) were significantly associated with a worse disease-free survival. CONCLUSIONS: Expression levels of MRN complex proteins significantly predict disease-free survival in rectal cancer patients, including those treated with neoadjuvant radiotherapy, and may have value in the management of these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4776-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-03 /pmc/articles/PMC6122630/ /pubmed/30176843 http://dx.doi.org/10.1186/s12885-018-4776-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ho, Vincent
Chung, Liping
Singh, Amandeep
Lea, Vivienne
Abubakar, Askar
Lim, Stephanie H.
Ng, Weng
Lee, Mark
de Souza, Paul
Shin, Joo-Shik
Lee, Cheok Soon
Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
title Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
title_full Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
title_fullStr Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
title_full_unstemmed Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
title_short Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
title_sort overexpression of the mre11-rad50-nbs1 (mrn) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122630/
https://www.ncbi.nlm.nih.gov/pubmed/30176843
http://dx.doi.org/10.1186/s12885-018-4776-9
work_keys_str_mv AT hovincent overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT chungliping overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT singhamandeep overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT leavivienne overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT abubakaraskar overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT limstephanieh overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT ngweng overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT leemark overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT desouzapaul overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT shinjooshik overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis
AT leecheoksoon overexpressionofthemre11rad50nbs1mrncomplexinrectalcancercorrelateswithpoorresponsetoneoadjuvantradiotherapyandprognosis